WallStSmart

Ostin Technology Group Co Ltd (OST)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 552% more annual revenue ($258.90M vs $39.68M). ZEPP leads profitability with a -15.5% profit margin vs -25.2%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

OST

Avoid

25

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 5.0Quality: 3.0
Piotroski: 4/9Altman Z: -0.87

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for OST.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

OST1 strengths · Avg: 10.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

OST4 concerns · Avg: 2.3/10
Market CapQuality
$10.11M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-109.4%2/10

ROE of -109.4% — below average capital efficiency

EPS GrowthGrowth
-16.1%2/10

Earnings declined 16.1%

Altman Z-ScoreHealth
-0.872/10

Distress zone — elevated risk

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : OST

The strongest argument for OST centers on Price/Book.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : OST

The primary concerns for OST are Market Cap, Return on Equity, EPS Growth. Debt-to-equity of 3.66 is elevated, increasing financial risk.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

OST profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor ELECTRONIC COMPONENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 25/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ostin Technology Group Co Ltd

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

Ostin Technology Group Co Ltd (OST) is a prominent player in the semiconductor industry, renowned for its high-performance computing and advanced semiconductor solutions. With a strong emphasis on research and development, OST utilizes innovative technologies to provide a range of products that improve operational efficiency across multiple sectors. As global demand for semiconductor technology escalates, driven by trends in artificial intelligence, IoT, and cloud computing, OST is well-positioned for sustained growth. The company’s strategic partnerships and unwavering commitment to innovation reinforce its competitive advantage in a fast-evolving technology landscape.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?